Skip to content
Catalyst

PapersPMID:34577880

Effects of Caffeinated and Decaffeinated Coffee Consumption on Metabolic Syndrome Parameters: A Systematic Review and Meta-Analysis of Data from Randomised Controlled Trials.

Medicina (Kaunas, Lithuania)2021The record ↗

  1. Finding, moderate evidencelowersTriglycerides

What moved

1 findingHow to read these marks →
  • “Overall, the meta−analysis showed that GCE supplementation had a small pooled effect size with a high level of heterogeneity on the mean reduction in TG levels (pooled effect size of −0.27, 95% CI: −0.43, −0.10; I2 = 88.9%).”
    Study
    meta-analysis
    Dose studied
    GCE 10 to 1000 mg, containing 180 to 500 mg CGA
    Population
    Adults in randomised trials of green coffee extract against a control group, mostly overweight or obese, dyslipidaemic, hypertensive or insulin resistant; long-term (8 to 24 weeks) interventions; some GCE arms were given alongside elastic resistance band training

Study record

Design
meta-analysis
Species
human
Population
Free-living men and women (aged from 18 to 70 years) with metabolic syndrome in RCTs of caffeinated coffee, decaffeinated coffee or green coffee extract
Participants
821
Comparator
not stated in the paper
Duration
not reported
Endpoints measured
19